Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Ipilimumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 14 Carcinoma, Renal Cell 12 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 4 Skin Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Merkel Cell 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Carcinoma 2

Interventions

fludarabine 1 belinostat 1 Cyclophosphamide 1 Azacitidine 1 Abatacept 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡